An epidemiology study of acquired heart disease is most useful when it defines one disease outcome clearly rather than treating every cardiovascular condition as though it has the same causes and natural history. Acquired heart disease includes coronary artery disease, heart failure, hypertensive heart disease, acquired valve disease, cardiomyopathy, arrhythmias, infective endocarditis, and other conditions that develop after birth. For a coherent population study, this proposal focuses on incident coronary heart disease (CHD) because its major risk factors are well characterized and because prospective follow-up can measure first clinical events more reliably than a one-time questionnaire.
The public-health importance remains substantial. Provisional U.S. mortality data for 2025 identified heart disease as the leading cause of death, with an estimated 694,708 deaths, while the American Heart Association’s 2026 statistical update continues to identify cardiovascular disease as a major source of mortality, disability, and healthcare burden (CDC/NCHS, 2026; American Heart Association [AHA], 2026). At the risk-factor level, CDC data show that nearly half of U.S. adults have high blood pressure and that smoking, elevated LDL cholesterol, poor nutrition, physical inactivity, type 2 diabetes, and obesity remain major preventable contributors to cardiovascular disease (CDC, 2025a, 2025b; World Health Organization [WHO], 2025). The epidemiological challenge is therefore not merely to list these factors but to measure how they predict incident disease, how they cluster in populations, and how their associations vary across social and demographic contexts.
Study Question and Design
The proposed research question is: Among U.S. adults aged 35–74 years who are free of clinically diagnosed coronary heart disease at baseline, how are modifiable cardiovascular risk factors associated with the incidence of first major coronary events during ten years of follow-up? The primary exposures are cigarette smoking, blood pressure, blood lipids, diabetes status, body mass index and waist circumference, physical activity, dietary pattern, and medication use. Socioeconomic and environmental factors are included because risk is not distributed independently of income, healthcare access, neighborhood conditions, work, stress, and other structural influences.
A prospective cohort design is appropriate because exposure is measured before the outcome occurs. This provides a clearer temporal sequence than the cross-sectional questionnaire approach used in the earlier version of the essay. Participants would be enrolled without prior myocardial infarction, coronary revascularization, or clinically diagnosed CHD and then followed for new events. A cohort study still cannot prove causality automatically because confounding, measurement error, loss to follow-up, and time-varying exposures remain possible, but it can directly estimate incidence and compare risk across exposure levels.
| Design element | Proposed approach |
|---|---|
| Target population | Noninstitutionalized U.S. adults aged 35–74 years without diagnosed CHD at baseline |
| Primary outcome | First nonfatal myocardial infarction or fatal coronary heart disease |
| Follow-up | 10 years, with annual contact and periodic repeat examinations |
| Core exposures | Smoking, blood pressure, lipids, diabetes, obesity, physical activity, diet, medication |
| Contextual variables | Age, sex, race/ethnicity, income, education, insurance, region, neighborhood conditions |
| Main analysis | Incidence rates and multivariable time-to-event models with prespecified confounders |
The age range is a design choice, not a statement that adults older than 74 are less important. Older adults have high cardiovascular burden, but competing mortality, multimorbidity, frailty, and treatment complexity can make a single etiologic model more difficult to interpret. A companion study could examine adults 75 years and older with methods designed for competing risks and multimorbidity. The main cohort should also oversample populations commonly underrepresented in cardiovascular research so that subgroup estimates are not based on very small numbers.
Measuring Exposure and Outcome
Baseline assessment should combine self-report with objective measurement. Blood pressure should be measured with validated equipment after appropriate rest and with repeated readings rather than defined from one measurement. Laboratory testing should include total cholesterol, HDL cholesterol, triglycerides, LDL cholesterol as appropriate, glucose, and hemoglobin A1c. Medication records are needed because treated blood pressure or cholesterol may look normal even though the participant has substantial underlying risk.
Smoking assessment should distinguish current, former, and never smoking and record intensity, duration, cessation, secondhand exposure, and other nicotine products. Physical activity should include leisure, occupational, household, and transportation activity, with accelerometry in at least a subsample to evaluate the limitations of self-report. Diet should be measured using a validated instrument capable of representing dietary patterns rather than isolating one nutrient as a universal cause.
Body mass index is useful for population surveillance but should not be treated as a complete measure of metabolic health. Waist circumference and, where feasible, additional measures of body composition can improve interpretation. The analysis should also recognize that obesity can function as both an exposure and an intermediate pathway through blood pressure, diabetes, inflammation, and other mechanisms. Statistical adjustment must therefore follow a prespecified causal model rather than automatically control for every available variable.
The primary outcome should be the first occurrence of fatal coronary heart disease or nonfatal myocardial infarction. Coronary disease is largely driven by atherosclerotic plaque accumulation in the coronary arteries, although thrombosis and other processes determine when clinical events occur (CDC, 2024). Potential events should be identified through hospital records, healthcare-system linkage, participant reports, and mortality data, then adjudicated using standardized criteria. Self-report alone is not sufficient because recall and diagnostic misunderstanding can misclassify outcomes.
Secondary outcomes could include unstable angina requiring hospitalization, coronary revascularization, heart failure, stroke, and all-cause mortality. These should remain secondary because combining different cardiovascular endpoints into one broad category can obscure important differences. The earlier article’s reference to triglycerides, blood viscosity, and heart disease illustrates this problem: lipid-related mechanisms may contribute to coronary risk, but they should be evaluated within a defined disease model rather than used to generalize across all acquired heart conditions.
Sampling, Follow-Up, and Bias Control
Participants could be recruited through a stratified combination of healthcare systems, population registries, community outreach, and geographically diverse sampling areas. Recruitment should not depend only on online volunteers, because health interest, internet access, and socioeconomic status would create selection bias. Materials should be available in relevant languages and accessible formats, and community partnerships can improve both trust and retention.
Sample size should be calculated from expected event rates, exposure prevalence, detectable effect sizes, planned subgroup analyses, number of covariates, and anticipated loss to follow-up. The earlier article used a specific participant number without providing such justification. A study designed to estimate interactions across demographic groups may require a much larger cohort than one designed only to estimate a main association.
Follow-up should include annual contact to identify hospitalizations, new diagnoses, medication changes, and major risk-factor changes, with repeat examinations at defined intervals such as years three, six, and ten. Risk factors such as blood pressure, smoking, weight, and diabetes status change over time. Treating them as permanently fixed at baseline can weaken the model, so time-varying analyses may be appropriate.
Three forms of bias deserve particular attention. Selection bias can occur if healthier, wealthier, or more health-conscious people are more likely to enroll or remain in the study. Information bias can result from inaccurate self-report, measurement error, or inconsistent outcome classification. Surveillance bias can occur when people with better healthcare access are more likely to have disease diagnosed. Probability-based recruitment, standardized measurement, objective outcomes, retention strategies, and appropriate weighting can reduce these problems but cannot eliminate them completely.
Missing data should be described rather than ignored. Complete-case analysis can distort results when missingness is associated with health or socioeconomic conditions. Multiple imputation and inverse-probability approaches may be appropriate under stated assumptions, with sensitivity analyses used to test whether conclusions change when those assumptions are altered.
Analysis Should Separate Prediction, Association, and Causation
Incidence should be reported as events per person-time with confidence intervals. Kaplan–Meier methods can describe cumulative event probability, while Cox proportional-hazards models or other time-to-event methods can estimate adjusted associations between risk factors and CHD. The proportional-hazards assumption should be tested, and nonlinear exposure relationships should be modeled flexibly rather than forcing continuous variables into arbitrary categories.
Confounders should be selected using subject-matter knowledge and causal reasoning rather than stepwise significance testing. Age, sex, family history, income, education, kidney function, medication, sleep, depression, air pollution, neighborhood conditions, and healthcare access may affect interpretation depending on the exposure being studied. Race and ethnicity should be treated as social and political categories that can capture exposure to structural conditions, not as simple biological causes.
Population-attributable fractions can be estimated to illustrate how much disease might theoretically be prevented if an exposure were reduced, but such estimates require causal assumptions. They should not be interpreted as guaranteed effects of a policy. Risk factors also overlap, so fractions for smoking, hypertension, diabetes, obesity, and lipids cannot simply be added as if each acted independently.
The study can contribute to both prediction and prevention, but the two goals should be distinguished. A variable may improve prediction without being an appropriate intervention target, while a causal risk factor may produce only a small increase in predictive accuracy if other variables already capture similar information. Epidemiology becomes more useful when the research question specifies whether the objective is etiologic understanding, risk prediction, disparity measurement, or intervention planning.
Equity and Public-Health Meaning
Cardiovascular risk factors are unevenly distributed across the United States. CDC’s 2025 national data brief found that 28.7 percent of adults had two or more major cardiovascular risk factors based on uncontrolled blood pressure, lipids, glucose, and high BMI during August 2021–August 2023, with differences by age, sex, and income (CDC/NCHS, 2025). These differences should not be interpreted as evidence that particular populations are inherently unhealthy. Housing, food access, healthcare coverage, occupational conditions, environmental exposure, stress, and historical inequities can shape both risk and treatment.
Ethical design therefore requires more than diverse recruitment. Participants should receive clear consent information, privacy protection, procedures for urgent clinical findings, and appropriate referral when dangerous results are identified. Community representatives can also help determine which questions matter and how findings should be communicated. Research that documents disparities without improving access to prevention risks becoming descriptive rather than useful.
The ultimate value of an epidemiological study is not the production of another list of risk factors. Current evidence already establishes high blood pressure, high LDL cholesterol, smoking, diabetes, poor nutrition, inactivity, and obesity as major modifiable contributors to cardiovascular risk (CDC, 2025a; AHA, 2026). The proposed cohort would add value by measuring how these factors combine, how risk changes over time, and how social conditions influence both exposure and outcomes. Such evidence can guide prevention, clinical screening, and public-health investment without pretending that observational associations are simple proof of causation.
References
American Heart Association. (2026). 2026 Heart Disease and Stroke Statistics: A Report of U.S. and Global Data.
Centers for Disease Control and Prevention. (2024). About Coronary Artery Disease.
Centers for Disease Control and Prevention. (2025a). Heart Disease Risk Factors.
Centers for Disease Control and Prevention. (2025b). About the Division for Heart Disease and Stroke Prevention.
Centers for Disease Control and Prevention, National Center for Health Statistics. (2025). Prevalence of Cardiovascular Disease Risk Factors in Adults: United States, August 2021–August 2023. NCHS Data Brief No. 540.
Centers for Disease Control and Prevention, National Center for Health Statistics. (2026). Mortality in the United States: Provisional Data, 2025.
World Health Organization. (2025). Cardiovascular Diseases.
Cite This Work
To export a reference to this article please select a referencing stye below:
Academic Master Education Team is a group of academic editors and subject specialists responsible for producing structured, research-backed essays across multiple disciplines. Each article is developed following Academic Master’s Editorial Policy and supported by credible academic references. The team ensures clarity, citation accuracy, and adherence to ethical academic writing standards
Content reviewed under Academic Master Editorial Policy.
